v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 733 $ 6,272 $ 733 $ 6,402
Operating expenses:        
Research and development 9,957 6,465 21,137 13,123
General and administrative 6,474 4,880 13,138 10,902
Total operating expenses 16,431 11,345 34,275 24,025
Loss from operations (15,698) (5,073) (33,542) (17,623)
Other income (expense), net 689 389 1,546 2,704
Loss before provision for income taxes (15,009) (4,684) (31,996) (14,919)
Provision for income taxes 0 0 0 0
Net loss $ (15,009) $ (4,684) $ (31,996) $ (14,919)
Series A Preferred Stock        
Operating expenses:        
Net loss per share, basic (in dollars per share) $ 0 $ (64.73) $ 0 $ (206.27)
Net loss per share, diluted (in dollars per share) $ 0 $ (64.73) $ 0 $ (206.27)
Weighted-average common shares outstanding, basic (in shares) 0 1,250 0 1,250
Weighted-average common shares outstanding, diluted (in shares) 0 1,250 0 1,250
Common Stock        
Operating expenses:        
Net loss per share, basic (in dollars per share) $ (0.08) $ (0.06) $ (0.19) $ (0.21)
Net loss per share, diluted (in dollars per share) $ (0.08) $ (0.06) $ (0.19) $ (0.21)
Weighted-average common shares outstanding, basic (in shares) 197,453,293 71,109,514 166,674,573 71,077,747
Weighted-average common shares outstanding, diluted (in shares) 197,453,293 71,109,514 166,674,573 71,077,747